TRIM33 and dermatomyositis: Among PM/DM-associated autoantibodies, anti-transcriptional intermediary factor 1-γ (TIF1-γ) antibody was most commonly detected in 24.4% of PM/DM patients, followed by anti-TIF1-α antibody (18.0%) and anti-PL-7 antibody (6.4%).